Primary adrenal insufficiency due to bilateral adrenal hemorrhage-adrenal infarction in the antiphospholipid syndrome: Long-term outcome of 16 patients

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 8, 2013, Pages 3179-3189

  Ramon, Isolde ^a   Mathian, Alexis ^c,e   Bachelot, Anne ^d,e   Hervier, Baptiste ^c,e   Haroche, Julien ^c   Huong, Du Boutin Le Thi ^c   Costedoat Chalumeau, Nathalie ^c,e   Wechsler, Bertrand ^c   Karmali, Rafik ^b   Velkeniers, Brigitte ^f   Touraine, Philippe ^d,e   Coussieu, Christiane ^c,e   Bennani, Abdelhai ^c   Renard Penna, Raphaele ^c   Grenier, Philippe A ^c   Wahl, Denis ^g,h   Piette, Jean Charles ^c   Amoura, Zahir ^c,e  

^a Centre Hospitalier Universitaire Ambroise Pare   (Belgium)

^b BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d Centre de Référence National Pour le Lupus et le Syndrome des Antiphospholipides   (France)

^e SORBONNE UNIVERSITÉ   (France)

^f UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^g UNIVERSITÉ DE LORRAINE   (France)

^h INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALDOSTERONE; HYDROCORTISONE; PRASTERONE;

ADOLESCENT; ADRENAL DISEASE; ADRENAL GLAND INFARCTION; ADRENAL HEMORRHAGE; ADRENAL INSUFFICIENCY; ADULT; ALDOSTERONE BLOOD LEVEL; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BRAIN HEMORRHAGE; CAUSE OF DEATH; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST; DISEASE COURSE; FEMALE; FRANCE; HUMAN; HYDROCORTISONE BLOOD LEVEL; INFARCTION; MALE; MORTALITY; ONSET AGE; OUTCOME ASSESSMENT; PRIMARY ADRENAL INSUFFICIENCY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; TETRACOSACTIDE TEST; THROMBOSIS; URINE LEVEL;

ADDISON DISEASE; ADOLESCENT; ADRENAL GLAND DISEASES; ADRENAL GLANDS; ADULT; ANTIPHOSPHOLIPID SYNDROME; CHILD; FEMALE; HEMORRHAGE; HUMANS; INFARCTION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84881538895     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-4300     Document Type: Article

References (28)

1. Chakera AJ, Vaidya B. Addison disease in adults: diagnosis and management. Am J Med. 2010;123:409-413.
2. Vella A, Nippoldt TB, Morris JC. Adrenal hemorrhage: a 25-year experience at the Mayo Clinic. Mayo Clin Proc. 2001;76:161-168.
3. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295-306.
4. Espinosa G, Santos E, Cervera R, et al. Adrenal involvement in the antiphospholipid syndrome: clinical and immunologic characteristics of 86 patients. Medicine (Baltimore). 2003;82:106-118.
5. Presotto F, Fornasini F, Betterle C, Federspil G, Rossato M. Acute adrenal failure as the heralding symptom of primary antiphospholipid syndrome: report of a case and review of the literature. Eur J Endocrinol. 2005;153:507-514.
6. Arnason JA, Graziano FM. Adrenal insufficiency in the antiphospholipid syndrome. Semin Arthritis Rheum. 1995;25:109-116.
7. Berneis K, Buitrago-Téllez C, Müller B, Keller U, Tsakiris DA. Antiphospholipid syndrome and endocrine damage: why bilateral adrenal thrombosis? Eur J Haematol. 2003;71:299-302.
8. Caron P, ChabannierMH, Cambus JP, Fortenfant F, Otal P, Suc JM. Definitive adrenal insufficiency due to bilateral adrenal hemorrhage and primary antiphospholipid syndrome. J Clin Endocrinol Metab. 1998;83:1437-1439.
9. Boneschansker L, Nijland M, Glaudemans AW, van der Meulen SB, Kluin PM, Dullaart RP. Adrenal hemorrhage causing adrenal insufficiency in a patient with antiphospholipid syndrome: increased adrenal 18F-FDG uptake. J Clin Endocrinol Metab. 2012;97:3014-3015.
10. Lê Thi Huong D, Wechsler B, Piette JC, et al. The antiphospholipid syndrome. A new cause of bilateral adrenal haemorrhage: 4 cases. Presse Med. 1993;22:249-254.
11. Vengrove MA, Amoroso. A Reversible adrenal insufficiency after adrenal hemorrhage. Ann Intern Med. 1993;119:439.
12. Boonen E, Vervenne H, Meersseman P. Reduced cortisol metabolism during critical illness.NEngl J Med. 2013;368(16):1477-1488.
13. Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1, 000 patients. Arthritis Rheum. 2002;46: 1019-1027.
14. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med. 2002;346:752-763.
15. Asherson RA, Cervera R, de Groot PG, et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus. 2003;12:530-534.
16. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.
17. Pengo V, Tripodi A, Reber G, et al. Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost. 2009;7:1737-1740.
18. Tincani A, Allegri F, Balestrieri G, et al. Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies. Thromb Res. 2004;114:553-558.
19. Chitale A, Musonda P, McGregor A, Dhatariya K. Determining the utility of the 60 min cortisol measurement in the short synacthen test. Clin Endocrinol (Oxf). 2013;79:14-19.
20. Cervera R, Khamashta MA, Shoenfeld Y, et al. Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis. 2009;68:1428-1432.
21. Ruiz-Irastorza G, Hunt BJ, Khamashta MA. A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies. Arthritis Rheum. 2007;57:1487-1495.
22. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GR. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med. 1995;332:993-997.
23. Crowther MA, Ginsberg JS, Julian J, et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome. N Engl J Med. 2003; 349:1133-1138.
24. Finazzi G, Marchioli R, Brancaccio V, et al. A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost. 2005; 3:848-853.
25. Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA. Antiphospholipid syndrome. Lancet. 2010;376:1498-1509.
26. Ruiz-Irastorza G, Khamashta MA, Hunt BJ, Escudero A, Cuadrado MJ, Hughes GR. Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5. Arch Intern Med. 2002;162:1164-1169.
27. Fox B. Venous infarction of the adrenal glands. J Pathol. 1976;119: 65-89.
28. Stewart PM. Adrenal replacement therapy: time for an inward look to the medulla? J Clin Endocrinol Metab. 2004;89:3677-3678.